This popular Spanish newspaper brings PSSD into discussion on a recent article covering the devastating impacts that can persist after stopping antidepressants. The article lets those who have been affected speak out, while also highlighting suicides caused from PSSD. An outdated prevalence study is continuously referenced as well.

An article from USA TODAY reflects on a recent speech presented by PSSD sufferer Lauren, who was one of the Safety Advocates on Mental Healthcare. Lauren did an amazing job representing the realness of PSSD, along with the disabling cognitive effects which sufferers also experience. The doctors whom were interviewed within the article agree that PSSD needs more research, especially as the true prevalence is still unknown.

An article from Unilad discusses a recent speech presented by PSSD sufferer Lauren, who was one of the Safety Advocates on Mental Healthcare. Lauren did an amazing job representing the realness of PSSD, along with the disabling cognitive effects which sufferers also experience. This Unilad article shares that speech from the PSSD Network X account.

An article from The Esquire reveals a distressing experience from Kyle MacNeill — regarding his experience of sexual dysfunction while on antidepressants. Multiple PSSD sufferers are interviewed, including someone who took 1 pill and has been suffering for years. The article highlights constant gaslighting from doctors and reinforces the urgent need for further recognition and answers.

An article from Iltalehti Finland by Ulla Ora shares the very real suffering of a PSSD victim, who describes their life as a now nightmare after taking an antidepressant. A psychiatrist who was interviewed for this article explains PSSD and its terrifying existence.

Researcher Antonei Csoka appears on Full Measure with Sharyl Attkisson and discusses the life-altering side effects of antidepressants. PSSD is discussed and hypothesized to be triggered by epigenetic changes, resulting in long-lasting sexual dysfunction after stopping the drugs. There are many unanswered questions brought up in this interview, and there are clues as to what is causing this.

“‘TRAUMATISED’ Common drugs have destroyed my sex life – I feel like I’ve got a dead piece of meat in my pants” By Isabel Shaw shares the story of PSSD sufferer Daryl, who discusses his experience with ongoing symptoms after stopping antidepressants. The article highlights Post-SSRI Sexual Dysfunction (PSSD) and quotes a study from 2023. PSSD Network is mentioned along with their effort to bring more research to the condition.

A follow-up article to The New York Times Magazine article on PSSD argues that the increasing use of antidepressants among Gen Z may be contributing to declining interest in dating, sex, and romantic relationships. The author discusses PSSD as one of the causes. Through personal accounts and emerging research, the article suggests that these effects may interfere with individuals’ ability to form and maintain romantic connections. While acknowledging that antidepressants provide important mental health benefits for some people, the author raises concerns about whether the long-term sexual and emotional consequences are fully understood or adequately communicated to patients, and questions whether they may be one factor behind broader declines in relationship formation among young adults.

“More Teens Are Taking Antidepressants. It Could Disrupt Their Sex Lives For Years.” By Daniel Berger exposes the ongoing scandal of Post-SSRI Sexual Dysfunction (PSSD) and highlights the question of why there are no deep studies looking into this problem. Many young patients are reporting diminished libido, muted orgasms, genital numbness and emotional blunting that persists well beyond the last dose. The article argues that this isn’t just a “side-effect” to gloss over but may fundamentally interfere with developing sexual selves, intimate relationships and one’s sense of embodiment at a formative age. What makes the story particularly compelling (and alarming) is the sense that this is happening partly in the shadows of medical consent and oversight. The piece calls for a more transparent, informed dialogue around antidepressants in youth—one that treats sexuality not as an afterthought but as a vital part of wellbeing.

Dr. Josef Witt-Doerring appears on Tucker Carlson and discusses the hidden and life-altering side effects of antidepressants, including debilitating withdrawal, PSSD, and suicide. PSSD sufferer Rosie is seen as an example throughout the interview as Witt-Doerring uses her story as awareness and a lesson to the medical field.

Medshadow Foundation’s recent article by Peg Rosen provides detailed stories of the devastating and often permanent condition known as Post-SSRI Sexual Dysfunction (PSSD), which can occur after stopping antidepressants. The controversy between antidepressants and PSSD has sparked a lot of public interest recently. Although PSSD is still thought of as rare, the article discusses that we need more data to actually confirm that.

In a recent article from NPR, Emily Corwin shares testimonials of patients who suffer from antidepressant withdrawal and PSSD. Many symptoms are described, however it seems to be known that genital numbness and emotional blunting are among the most common symptoms after discontinuing the drugs. The article also covers the controversy between RFK Jr and his criticism of antidepressants, and how this could be bad news for funding, as explained that Trump has cut federal funding for Biomedical research.

An article from Freedom Magazine exposes the often permanent damage caused by Post-SSRI Sexual Dysfunction (PSSD). Despite calls for FDA action since 2018, warning labels remain absent. Sufferers report devastating symptoms like genital numbness and emotional blunting, yet psychiatrists often dismiss them. The PSSD Network continues to push for recognition, support, and research. Heartbreakingly, some—like Mary Koback—have died by suicide after being left without answers.

This powerful article from the Irish Independent shares the stories of 13 Irish women navigating the emotional, physical, and medical challenges of perimenopause and menopause. It highlights widespread issues with misdiagnosis, the over-prescription of antidepressants, and the lack of access to proper hormonal care. Crucially, one woman bravely speaks out about developing Post-SSRI Sexual Dysfunction (PSSD) after being placed on antidepressants—raising urgent concerns about how often hormone-related symptoms are being mistreated with psychiatric drugs.

The Swedish article by Katarina Forsberg discusses new research pointing to further evidence of PSSD. Doctors are asked what their thoughts on PSSD entail, with one of them expressing that “It has taken time for this problem to receive attention”. Approximately 1.2 million Swedes took antidepressants in 2023. How many of them are now suffering from PSSD?

Taking place in Sweden, this piece on loss of libido by Lisa Wallström encompasses a myriad of symptoms due to the discontinuation of antidepressants. Wallström explains that there is an increasing concern of PSSD spreading worldwide. The symptoms covered in this article are discussed in sexual and cognitive aspects, such as no libido, weak orgasm, and emotional blunting persisting after stopping the drug. As research articles are referenced, the article portrays a lack of research and the need for a better understanding of the condition.

An article from Finland by Anniina Nikander sheds light on the hidden antidepressant side effect, PSSD. One sufferer says “I will live the rest of my life as a mere shell of a person”. Some controversy strikes as a doctor claims to have seen dozens of cases, but believes that future patients should not be warned of PSSD. Other victims of the condition claim they would have been dead by now if they didn’t have the validation and support from their partners.

Following her initial report on the lawsuit in may 2024 against the FDA for not responding to a 2018 citizen’s petition, Australian journalist Maryanne Demasi provides an update: the case has unfortunately been dismissed on a technicality. In her latest piece, Demasi sheds light on the ongoing challenges faced by people with PSSD and other harmed patient communities in getting their voices heard and holding powerful institutions like the FDA accountable.

Jan Jekielek is a Senior Editor with The Epoch Times who interviews Dr. Josef Witt-Doerring on American Thought Leaders (Epoch TV) surrounding the concerns of PSSD and Protracted Withdrawal. Witt-Doerring is presented with many questions surrounding PSSD, in which he answers through his knowledge via academic sources and patient testimonies from his Youtube channel. Jekielek and Witt-Doerring both come to an agreement that these drugs are too overprescribed, and there needs to be more transparency surrounding iatrogenic harm.

Yassie Pirani (RSW, RCC) and Travis Salway (PHD) take on a presentation of their latest cross-sectional survey regarding PSSD. While the result was shocking, they both wanted to share their findings, patient testimonies, and further research surrounding the condition at BCCDC. This presentation is very informative for those looking to learn more about PSSD.